Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies

Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies

Thomas P Lodise,1 Jingyi Li,2 Hitesh N Gandhi,3 Gerald O’Brien,3 Sanjay Sethi4 1Department of Pharmacy Practice, Albany College Pharmacy and Health Sciences, Albany, NY, USA; 2Global Medical Affairs, AstraZeneca, Gaithersburg, MD, USA; 3US Respiratory Medical, AstraZeneca, Wilmington, DE,...

Full description

Bibliographic Details
Main Authors: Lodise TP, Li J, Gandhi HN, O’Brien G, Sethi S
Format: Article
Language:English
Published: Dove Medical Press 2020-11-01
Series:International Journal of COPD
Subjects:
inhaled corticosteroids
pneumonia
copd.
Online Access:https://www.dovepress.com/intraclass-difference-in-pneumonia-risk-with-fluticasone-and-budesonid-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/intraclass-difference-in-pneumonia-risk-with-fluticasone-and-budesonid-peer-reviewed-article-COPD

Similar Items